Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

ATRC
AtriCure, Inc.
stock NASDAQ

Market Open
Jul 28, 2026 2:12:52 PM EDT
39.02USD+4.415%(+1.65)497,913
38.97Bid   39.05Ask   0.08Spread
Pre-market
Jul 27, 2026 9:28:00 AM EDT
35.89USD+2.426%(+0.85)0
After-hours
Jul 27, 2026 4:00:30 PM EDT
37.37USD+0.027%(+0.01)0
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 25, 2022
08:00AM EST  AtriCure to Announce Fourth Quarter and Full Year 2021 Financial Results   Business Wire
Jan 10, 2022
07:28AM EST  AtriCure Sees Q4 Sales ~$73.2M Vs. $72.53M Est., FY22 Sales $315M-$330M Vs. $321.67M Est.   Benzinga
07:10AM EST  AtriCure Q4 Prelim. Revenue Up 27% To $73.2 Mln   RTTNews
07:00AM EST  AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2021, Provides Financial Outlook for 2022   Business Wire
Dec 20, 2021
08:00AM EST  AtriCure to Participate in the 40th Annual J.P. Morgan Healthcare Conference   Business Wire
Nov 12, 2021
08:00AM EST  AtriCure to Participate in Upcoming Piper Sandler 33rd Annual Virtual Healthcare Conference   Business Wire
Nov 4, 2021
05:44AM EDT  Needham Maintains Buy on AtriCure, Raises Price Target to $92   Benzinga
05:25AM EDT  SVB Leerink Maintains Outperform on AtriCure, Raises Price Target to $110   Benzinga
Nov 3, 2021
07:02PM EDT  UPDATE: AtriCure Q3 Adj. EPS $(0.23) Beats $(0.33) Estimate   Benzinga
04:20PM EDT  AtriCure Reaffirms FY21 Guidance   Benzinga
04:20PM EDT  AtriCure Q3 EPS $2.11 Up From $(0.11) YoY, Sales $70.50M Beat $68.68M Estimate   Benzinga
04:02PM EDT  AtriCure Reports Third Quarter 2021 Financial Results   Business Wire
09:19AM EDT  The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering   Benzinga
09:10AM EDT  Earnings Scheduled For November 3, 2021   Benzinga
Oct 31, 2021
02:24PM EDT  The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline   Benzinga
Oct 26, 2021
08:00AM EDT  AtriCure to Participate in Upcoming Investor Conferences   Business Wire
Oct 5, 2021
08:00AM EDT  AtriCure to Announce Third Quarter 2021 Financial Results   Business Wire
Aug 31, 2021
08:00AM EDT  AtriCure to Participate at the Morgan Stanley 19th Annual Global Healthcare Conference   Business Wire
Aug 20, 2021
01:55PM EDT  Return on Capital Employed Insights for AtriCure   Benzinga
Aug 6, 2021
07:42AM EDT  The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO   Benzinga
Aug 5, 2021
10:07AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2021   Benzinga
08:03AM EDT  Canaccord Genuity Maintains Buy on AtriCure, Raises Price Target to $120   Benzinga
07:41AM EDT  Oppenheimer Downgrades AtriCure to Perform   Benzinga
05:53AM EDT  SVB Leerink Maintains Outperform on AtriCure, Raises Price Target to $100   Benzinga
05:43AM EDT  Needham Maintains Buy on AtriCure, Lowers Price Target to $90   Benzinga
Aug 4, 2021
04:33PM EDT  AtriCure Sees FY21 Sales $270M-$275M Vs. $254.77M Est.   Benzinga
04:32PM EDT  AtriCure Q2 EPS $(0.30) Beats $(0.33) Estimate, Sales $71.38M Beat $61.07M Estimate   Benzinga
04:01PM EDT  AtriCure Reports Second Quarter 2021 Financial Results   Business Wire
04:10AM EDT  Earnings Scheduled For August 4, 2021   Benzinga
Aug 3, 2021
07:55AM EDT  The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business   Benzinga
Jul 30, 2021
08:00AM EDT  AtriCure to Participate at the Canaccord 41st Annual Growth Conference   Business Wire
Jul 13, 2021
08:05AM EDT  The Daily Biotech Pulse: Equillium Issues Positive Regulatory Update, Biogen In-Licenses Multiple Sclerosis Drug, Aridis Releases COVID-19 Antibody Cocktail Data   Benzinga
Jul 9, 2021
07:36AM EDT  The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO   Benzinga
Jul 8, 2021
07:45AM EDT  The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test   Benzinga
Jul 7, 2021
08:00AM EDT  AtriCure to Announce Second Quarter 2021 Financial Results   Business Wire
Jun 29, 2021
08:17AM EDT  The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout   Benzinga
Jun 15, 2021
07:07AM EDT  AtriCure Names Deborah Telman And Maggie Yuen To Board   RTTNews
07:00AM EDT  AtriCure Names Two New Members to the Board of Directors   Business Wire
May 26, 2021
08:54AM EDT  Expert Ratings for AtriCure   Benzinga
08:32AM EDT  10 Biggest Price Target Changes For Wednesday   Benzinga
06:09AM EDT  SVB Leerink Maintains Outperform on AtriCure, Raises Price Target to $95   Benzinga
May 14, 2021
09:43AM EDT  JP Morgan Maintains Overweight on AtriCure, Raises Price Target to $81   Benzinga
Apr 30, 2021
09:20AM EDT  Canaccord Genuity Maintains Buy on AtriCure, Raises Price Target to $102   Benzinga
07:31AM EDT  The Daily Biotech Pulse: Hyperphosphatemia Drug Regulatory Review Extended, Phathom Pharma Data Readout, 2 IPOs   Benzinga
Apr 29, 2021
11:48AM EDT  CORRECTION: Credit Suisse maintains AtriCure (NASDAQ:ATRC) with a Buy and raises the price target from $81 to $91 - Correct Analyst Firm Needham   Benzinga
11:44AM EDT  Credit Suisse Maintains Buy on AtriCure, Raises Price Target to $91   Benzinga
07:13AM EDT  AtriCure Reports Its EPi-Sense System Approved By FDA For Treatment Of Long-Standing Persistent Afib Patients   Benzinga
07:05AM EDT  AtriCure's EPi-Sense System Approved by FDA for Treatment of Long-Standing Persistent Afib Patients   Benzinga
Apr 28, 2021
07:58AM EDT  Oppenheimer Maintains Outperform on AtriCure, Raises Price Target to $75   Benzinga
07:08AM EDT  Needham Maintains Buy on AtriCure, Raises Price Target to $81   Benzinga
Apr 27, 2021
04:37PM EDT  AtriCure: Q1 Earnings Insights   Benzinga
04:18PM EDT  AtriCure Sees FY21 Sales $252M-$256M Vs. $250.29M Est.   Benzinga
04:17PM EDT  AtriCure Q1 EPS $(0.32) Beats $(0.37) Estimate, Sales $59.30M Beat $56.06M Estimate   Benzinga
04:01PM EDT  AtriCure Reports First Quarter 2021 Financial Results   Business Wire
07:41AM EDT  The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout   Benzinga
04:05AM EDT  Earnings Scheduled For April 27, 2021   Benzinga
Apr 26, 2021
10:37AM EDT  Preview: AtriCure's Earnings   Benzinga
Apr 24, 2021
09:24AM EDT  The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx   Benzinga
Apr 23, 2021
07:28AM EDT  The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs   Benzinga
Apr 21, 2021
07:31AM EDT  The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue   Benzinga
Apr 20, 2021
08:07AM EDT  The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma's Epidiolex   Benzinga
Apr 8, 2021
08:12AM EDT  AtriCure Names B. Kristine Johnson Board Chair   Benzinga
Apr 6, 2021
08:00AM EDT  AtriCure to Announce First Quarter 2021 Financial Results   Business Wire
Mar 2, 2021
04:01PM EST  AtriCure to Participate at the Oppenheimer 31st Annual Healthcare Conference   Business Wire
08:01AM EST  The Daily Biotech Pulse: Roxadustat Delay For FibroGen, AstraZeneca, Decision Day For KemPharm, NanoViricides Jumps On COVID-19 Drug Data   Benzinga
Feb 24, 2021
07:47AM EST  10 Biggest Price Target Changes For Wednesday   Benzinga
07:30AM EST  The Daily Biotech Pulse: Bausch Calls Truce With Icahn, Pfizer's Brain Inflammation Vaccine Gets Priority Review, BriaCell IPO   Benzinga
06:14AM EST  SVB Leerink Maintains Outperform on AtriCure, Raises Price Target to $78   Benzinga
05:29AM EST  Needham Maintains Buy on AtriCure, Raises Price Target to $74   Benzinga
Feb 23, 2021
04:25PM EST  AtriCure: Q4 Earnings Insights   Benzinga
04:04PM EST  Atricure Sees Q1 Sales $55M-$57M vs $59.3M Estimate, Adj. EPS $(0.39)-$(0.36)   Benzinga
04:03PM EST  Atricure Sees FY21 Adj. EBITDA Loss $10M, Adj. EPS $(1.15), Sales ~$250M   Benzinga
04:02PM EST  AtriCure Q4 Adj. EPS $(0.18) Beats $(0.28) Estimate, Sales $57.70M Miss $58.10M Estimate   Benzinga
04:01PM EST  AtriCure Reports Fourth Quarter 2020 and Full Year 2020 Financial Results   Business Wire
07:25AM EST  The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts   Benzinga
04:09AM EST  Earnings Scheduled For February 23, 2021   Benzinga
Feb 22, 2021
10:19AM EST  Earnings Preview: AtriCure   Benzinga
Feb 11, 2021
11:21AM EST  Stocks That Hit 52-Week Highs On Thursday   Benzinga
Feb 10, 2021
08:00AM EST  AtriCure to Participate at the SVB Leerink 10th Annual Global Healthcare Conference   Business Wire
Feb 9, 2021
08:10AM EST  The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement   Benzinga
Feb 3, 2021
07:31AM EST  The Daily Biotech Pulse: Amgen Earnings, GSK-CureVac Vaccine Collaboration, Mallinckrodt FDA Decision   Benzinga
Feb 2, 2021
08:00AM EST  AtriCure to Announce Fourth Quarter and Full Year 2020 Financial Results   Business Wire
Jan 28, 2021
08:03AM EST  The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO   Benzinga
Jan 22, 2021
09:51AM EST  Needham Maintains AtriCure as Top Small/Mid-Cap Pick; Warns on Lower Revenue for Q4 Following Management Preannouncement However Highlights Upcoming Data from aMAZE Trial within Late 2021 as Major Catalyst with Near-Term Growth Driven by New Products   Benzinga
Jan 13, 2021
07:25AM EST  The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations   Benzinga
Jan 12, 2021
08:16AM EST  The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue   Benzinga
Jan 11, 2021
07:24AM EST  AtriCure Sees Q4 Sales $57.7M Vs. $58.1M Est.   Benzinga
07:21AM EST  AtriCure Sees Q4 Revenue At About $57.7 Mln, Down 6% From Last Year   RTTNews
07:00AM EST  AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2020   Business Wire
Jan 4, 2021
08:10AM EST  AtriCure Announces Labeling Expansion For Cryo Nerve Block Therapy   Benzinga
Dec 29, 2020
08:09AM EST  The Daily Biotech Pulse: FDA Nod For Amphastar's Generic Glucagon, Arcturus Sinks On Vaccine Data, Decision Day For Osmotica   Benzinga
Dec 23, 2020
08:31AM EST  The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut   Benzinga
Dec 22, 2020
07:45AM EST  The Daily Biotech Pulse: Ziopharm To Start Blood Cancer Study, Chemocentryx & Soligenix Slump On Adverse Clinical Trial Outcomes   Benzinga
Dec 18, 2020
07:48AM EST  The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Vote, Mesoblast Sinks On Data   Benzinga
07:45AM EST  The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Approved, Mesoblast Sinks On Data   Benzinga
Dec 14, 2020
08:00AM EST  AtriCure to Participate in the 39th Annual J.P. Morgan Healthcare Conference   Business Wire
05:26AM EST  SVB Leerink Maintains Outperform on AtriCure, Raises Price Target to $65   Benzinga
Nov 19, 2020
11:44AM EST  Insider Buys AtriCure Stock   Benzinga
08:00AM EST  AtriCure to Participate in Upcoming Piper Sandler 32nd Annual Virtual Healthcare Conference   Business Wire
Nov 6, 2020
05:40AM EST  Needham Maintains Buy on AtriCure, Lowers Price Target to $53   Benzinga
Nov 5, 2020
04:20PM EST  AtriCure Q3 EPS $(0.11) Up From $(0.33) YoY, Sales $54.76M Beat $49.37M Estimate   Benzinga
04:01PM EST  AtriCure Reports Third Quarter 2020 Financial Results   Business Wire
07:54AM EST  The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping   Benzinga
04:34AM EST  Earnings Scheduled For November 5, 2020   Benzinga
Nov 1, 2020
09:40AM EST  The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings   Benzinga
Oct 26, 2020
08:00AM EDT  AtriCure to Participate in Upcoming Investor Conferences   Business Wire
Oct 13, 2020
08:00AM EDT  AtriCure to Announce Third Quarter 2020 Financial Results   Business Wire
Sep 30, 2020
10:44AM EDT  Shares of AtriCure Inc. (ATRC) are falling more than 5 percent or $2.10 in Wednesday's morning trade at $37.92.   RTTNews
Sep 1, 2020
08:00AM EDT  AtriCure to Participate at the Morgan Stanley 18th Annual Global Healthcare Conference   Business Wire
Aug 6, 2020
04:00PM EDT  AtriCure Announces Angie Wirick as Chief Financial Officer   Benzinga
Jul 29, 2020
01:32PM EDT  JP Morgan Maintains Overweight on AtriCure, Raises Price Target to $57   Benzinga
12:15PM EDT  Piper Sandler Maintains Overweight on AtriCure, Raises Price Target to $50   Benzinga
08:00AM EDT  AtriCure to Participate at Upcoming Investor Conferences   Business Wire
06:40AM EDT  SVB Leerink Maintains Outperform on AtriCure, Raises Price Target to $60   Benzinga
Jul 28, 2020
04:23PM EDT  Recap: AtriCure Q2 Earnings   Benzinga
04:05PM EDT  AtriCure Q2 EPS $(0.38) Beats $(0.61) Estimate   Benzinga
04:01PM EDT  AtriCure Reports Second Quarter 2020 Financial Results   Business Wire
04:05AM EDT  Earnings Scheduled For July 28, 2020   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC